Open AccessP330: TARGETING BTN2A1 BY A UNIQUE ACTIVATING MAB IMPROVES ANTI‐TUMOR FUNCTIONS OF VΓ9VΔ2 T CELLS
Author(s) -
Le Floch A.C.,
Imbert C.,
Gassart A.,
Le Roy A.,
Gorvel L.,
Vey N.,
Anastasio A.,
Briantais A.,
Boucherit N.,
Cano C. E.,
Olive D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844208.32674.f6
Subject(s) - cytotoxic t cell , cancer research , cancer immunotherapy , t cell , immunotherapy , cytolysis , cancer cell , monoclonal antibody , cancer , immunology , biology , antibody , medicine , in vitro , immune system , biochemistry